Abstract |
It has been established that poor outcomes in ischemic stroke patients are associated with the post-reperfusion inflammatory response and up-regulation of TLR4. Therefore, suppression of the TLR4 signaling pathway constitutes a potential neuroprotective therapeutic strategy. Schisandrin B, a compound extracted from Schisandra chinensis, has been shown to possess anti-inflammatory and neuroprotective properties. However, the mechanism remains unclear. In the present study, the therapeutic effect of schisandrin B was assessed following cerebral ischemia and reperfusion (I/R) injury in a model of middle cerebral artery occlusion and reperfusion (MCAO/R) in rats. The effects of schisandrin B were investigated with particular emphasis on TLR4 signal transduction and on the inflammatory response. Schisandrin B treatment conferred significant protection against MCAO/R injury, as evidenced by decreases in infarct volume, neurological score, and the number of apoptotic neurons and inflammatory signaling molecules. ABBREVIATIONS:
|
Authors | Xingjuan Fan, Kenneth Elkin, Yunwei Shi, Zhihong Zhang, Yaqin Cheng, Jingxiao Gu, Jiale Liang, Caiping Wang, Xunming Ji |
Journal | Neurological research
(Neurol Res)
Vol. 42
Issue 8
Pg. 693-702
(Aug 2020)
ISSN: 1743-1328 [Electronic] England |
PMID | 32657248
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Cyclooctanes
- Lignans
- NF-kappa B
- Polycyclic Compounds
- Tlr4 protein, rat
- Toll-Like Receptor 4
- schizandrin B
|
Topics |
- Animals
- Anti-Inflammatory Agents
(administration & dosage)
- Brain Ischemia
(complications, metabolism, prevention & control)
- Cyclooctanes
(administration & dosage)
- Lignans
(administration & dosage)
- Male
- NF-kappa B
(metabolism)
- Polycyclic Compounds
(administration & dosage)
- Rats, Sprague-Dawley
- Reperfusion Injury
(complications, metabolism, prevention & control)
- Signal Transduction
(drug effects)
- Toll-Like Receptor 4
(metabolism)
|